Neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product

Toxicological Sciences

Volumn 128, Issue 1, 2012, Pages 223-234

  Garcia, Raphael Caio Tamborelli ^a   Dati, Livia Mendonça Munhoz ^a   Fukuda, Suelen ^a   Torres, Larissa Helena Lobo ^a   Moura, Sidnei ^b   De carvalho, Nathalia Delazeri ^c   Carrettiero, Daniel Carneiro ^d   Camarini, Rosana ^a   Levada pires, Adriana Cristina ^a   Yonamine, Mauricio ^a   Negrini neto, Osvaldo ^e   Abdalla, Fernando Maurício Francis ^c   Sandoval, Maria Regina Lopes ^c   Afeche, Solange Castro ^c   Marcourakis, Tania ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^e Forensic Toxicology and Chemistry Laboratory Criminalistic Institute of Sao Paulo   (Brazil)

Author keywords

Anhydroecgonine methyl ester; Crack cocaine; Neurotoxicity; Rat primary hippocampal cell culture

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ATROPINE; CASPASE 3; COCAINE; ECGONINE METHYL ESTER; LACTATE DEHYDROGENASE; MUSCARINIC RECEPTOR; NEUROTOXIN;

ANIMAL CELL; ANTICHOLINERGIC EFFECT; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; INCUBATION TIME; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PYROLYSIS; RAT; SMOKING;

ANIMALS; CELLS, CULTURED; COCAINE; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; PREGNANCY; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; TRITIUM;

RATTUS;

EID: 84864139022     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs140     Document Type: Article

References (64)

1. Abe, K., and Saito, H. (1999). Both oxidative stress-dependent and independent effects of amyloid β protein are detected by (3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Brain Res. 830, 146-154.
2. Abdalla, F. M. F., Maróstica, E., Picarelli, Z. P., Abreu, L. C., Avellar, M. C. W., and Porto, C. S. (2004). Effect of estrogen on muscarinic acetylcholine receptor expression in rat myometrium. Mol. Cell. Endocrinol. 213, 139-148.
3. Aksenov, M. Y., Aksenova, M. V., Nath, A., Ray, P. D., Mactutus, C. F., and Booze, R. M. (2006). Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: The role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27, 217-228.
4. Bisaglia, M., Soriano, M. E., Arduini, I., Mammi, S., and Bubacco, L. (2010). Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: Implications for mitochondrial dysfunctions in Parkinson disease. Biochim. Biophys. Acta 1802, 699-706.
5. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Bradley, K. N., Rowan, E. G., and Harvey, A. L. (2003). Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese hamster ovary cells. Toxicon 41, 207-215.
7. Brewer, G. J., Torricelli, J. R., Evege, E. K., and Price, P. J. (1993). Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
8. Brown, E., Prager, J., Lee, H. Y., and Ramsey, R. G. (1992). CNS complications of cocaine abuse: Prevalence, pathophysiology, and neuroradiology. Am. J. Roentgenol. 159, 137-147.
9. Cardoso, C. C., Pereira, R. T. S., Koyama, C. A., Porto, C. S., and Abdalla, F. M. F. (2004). Effects of estrogen on muscarinic acetylcholine receptors in the rat hippocampus. Neuroendocrinology 80, 379-386.
10. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
11. Cornish, J. W., and O'Brien, C. P. (1996). Crack cocaine abuse: An epidemic with many public health consequences. Annu. Rev. Pub. Health 17, 259-273.
12. Cunha, P. J., Nicastri, S., Gomes, L. P., Moino, R. M., and Peluso, M. A. (2004). Neuropsychological impairments in crack cocaine-dependent inpatients: Preliminary findings. Rev. Bras. Psiquiatr. 26, 103-106.
13. Cunha-Oliveira, T., Rego, A. C., Cardoso, S. M., Borges, F., Swerdlow, R. H., Macedo, T., and Oliveira, C. R. (2006). Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res. 1089, 44-54.
14. Cunha-Oliveira, T., Rego, A. C., and Oliveira, C. R. (2008). Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res. Rev. 58, 192-208.
15. Cunha-Oliveira, T., Rego, A. C., Garrido, J., Borges, F., and Oliveira, C. R. (2010). Neurotoxicity of heroin-cocaine combinations in rat cortical neurons. Toxicology 276, 11-17.
16. Darke, S., Kaye, S., and Topp, L. (2002). Cocaine use in New South Wales, Australia 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug Alcohol Depend. 67, 81-88.
17. De Oliveira, L.G., Barroso, L. P., Silveira, C. M., Sanchez, Z. V. D. M., Ponce, J. C., Vaz, L. J., and Nappo, S. A. (2009). Neuropsychological assessment of current and past crack cocaine users. Subst. Use Misuse 44, 1941-1957.
18. Di Sclafani, V., Tolou-Shams, M., Price, L. J., and Fein, G. (2002). Neuropsychological performance of individuals dependent on crack-cocaine, crackcocaine and alcohol at 6 week and 6 months of abstinence. Drug Alcohol Depend. 66, 161-171.
19. Dietrich, J. B., Poirier, R., Aunis, D., and Zwiller, J. (2004). Cocaine downregulates the expression of the mitochondrial genome in rat brain. Ann. NY Acad. Sci. 1025, 345-350.
20. Dietrich, J. B., Mangeol, A., Revel, M. O., Burgun, C., Aunis, D., and Zwiller, J. (2005). Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48, 965-974.
21. Dong, G. Z., Kameyama, K., Rinken, A., and Haga, T. (1995). Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells. J. Pharmacol. Exp. Ther. 274, 378-384.
22. Erzouki, H. K., Allen, A. C., Newman, A. H., Goldberg, S. R., and Schindler, C. W. (1995). Effects of cocaine, cocaine metabolites and cocaine pyrolysis products on the hindbrain cardiac and respiratory centers of the rabbit. Life Sci. 57, 1861-1868.
23. Fandiño, A. S., Toennes, S. W., and Kauert, G. F. (2002). Studies on hydrolytic and oxidative metabolic pathways of anhydroecgonine methyl ester (methylecgonidine) using microssomal preparations from rat organs. Chem. Res. Toxicol. 15, 1543-1548.
24. Fischer, B., Rehm, J., Patra, J., Kalousek, K., Haydon, E., Tyndall, M. W., and El-Guebaly, N. (2006). Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 101, 1760-1770.
25. Flynn, D. D., Vaishnav, A. A., and Mash, D. C. (1992). Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol. Pharmacol. 41, 736-742.
26. Goodman, J. H., and Sloviter, R. S. (1993). Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus: A silver degeneration and immunocytochemical study. Brain Res. 616, 263-272.
27. Gossop, M., Marsden, J., Stewart, D., and Kidd, T. (2002). Changes in use of crack cocaine after drug misuse treatment: 4-5 Year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug Alcohol Depend. 66, 21-28.
28. Haasen, C., Prinzleve, M., Zurhold, H., Rehm, J., Güttinger, F., Fischer, G., Jagsch, R., Olsson, B., Ekendahl, M., Verster, A., et al. (2004). Cocaine use in Europe - A multi-centre study. Eur. Addict. Res. 10, 139-146.
29. Haasen, C., Prinzleve, M., Gossop, M., Fischer, G., and Casas, M. (2005). Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry 4, 173-176.
30. Hamid, A. (1992). The developmental cycle of a drug epidemic: The cocaine smoking epidemic of 1981-1991. J. Psychoactive Drugs 24, 337-348.
31. Huber, J. D., Darling, S. F., Park, K. K., and Soliman, K. F. A. (2001). The role of NMDA receptors in neonatal cocaine-induced neurotoxicity. Pharmacol. Biochem. Behav. 69, 451-459.
32. Imam, S. Z., Duhart, H. M., Skinner, J. T., and Ali, S. F. (2005). Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: A possible mechanism of neurotoxic damage in cocaine addiction. Ann. NY Acad. Sci. 1053, 482-490.
33. Ioudina, M., Uemura E., and Greenlee, H. W. (2004). Glucose insufficiency alters neuronal viability and increases susceptibility to glutamate toxicity. Brain Res. 1004, 188-192.
34. Jahr, C. E., and Stevens, C. F. (1987). Glutamate activates multiple single channel conductances in hippocampal neurons. Nature 325, 522-525.
35. Jayalakshmi, K., Sairam, M., Singh, S. B., Sharma, S. K., Ilavazhagan, G., and Banerjee, P. K. (2005). Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture. Brain Res. 1046, 97-104.
36. Kline, R. H., Wright, J., Fox, K. M., and Eldefrawi, M. E. (1990). Synthesis of 3-arylecgonine analogues as inhibitors of cocaine binding and dopamine uptake. J. Med. Chem. 33, 2024-2027.
37. Kovacic, P. (2005). Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: Electron transfer and reactive oxygen species. Med. Hypotheses 65, 90-96.
38. Lendvai, B., and Vizi, E. S. (2008). Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol. Rev. 88, 333-349.
39. Lepsch, L. B., Munhoz, C. D., Kawamoto, E. M., Yshii, L. M., Lima, L. S., Curi-Boaventura, M. F., Salgado, T. M., Curi, R., Planeta, C. S., and Scavone, C. (2009). Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol. Brain 2.
40. Liu, Y., Peterson, D. A., Kimura, H., and Schubert, D. (1997). Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581-593.
41. Marsden, J., Eastwood, B., Bradbury, C., Dale-Perera, A., Farrel, M., Hammond, P., Knight, J., Randhawa, K., and Wright, C. (2009). Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study. Lancet 374, 1262-1270.
42. Martin, B. R., Lue, L. P., and Boni, J. P. (1989). Pyrolysis and volatilization of cocaine. J. Anal. Toxicol. 13, 158-162.
43. Melo, E. S., Barbeiro, D. F., Gorjão, R., Rios, E. C. S., Vasconcelos, D., Velasco, I. T., Szabo, C., Curi, R., Lima-Salgado, T. M., and Soriano, F. G. (2010). Gene expression reprogramming protects macrophage from septic-induced cell death. Mol. Immunol. 47, 2587-2593.
44. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
45. Nakahara, Y., and Ishigami, A. (1991). Inhalation efficiency of free-base cocaine by pyrolysis of 'crack' and cocaine hydrochloride. J. Anal. Toxicol. 15, 105-109.
46. Niu, L., Abood, L. G., and Hess, G. P. (1995). Cocaine: Mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc. Natl. Acad. Sci. U.S.A. 92, 12008-12012.
47. Oliveira, L. G., and Nappo, S. A. (2008). Characterization of the crack cocaine culture in the city of São Paulo: A controlled pattern of use. Rev. Saude Publ. 42, 664-671.
48. Otmakhova, N. A., and Lisman, J. E. (1996). D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 16, 7478-7486.
49. Pavarin, R. M. (2006). Substance use and related problems: A study on the abuse of recreational and not recreational drugs in Northern Italy. Ann. Ist Super Sanità 42, 477-484.
50. Paul, B. D., Lalani, S., Bosy, T., Jacobs, A. J., and Huestis, M. A. (2005). Concentrations profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: Determination by gas chromatographymass spectrometry. Biomed. Chromatogr. 19, 677-688.
51. Poon, H. F., Abdullah, L., Mullan, M. A., Mullan, M. J., and Crawford, F. C. (2007). Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem. Int. 50, 69-73.
52. Reid, M. S., Flammino, F., Howard, B., Nilsen, D., and Prichep, L. S. (2006). Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans. Neuropsychopharmacol. 31, 872-884.
53. Scheidweiler, K. B., Plessinger, M. A., Shojaie, J., Wood, R. W., and Kwong, T. C. (2003). Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate. J. Pharmacol. Exp. Ther. 307, 1179-1187.
54. Schilström, B., Yaka, R., Argili, E., Suvarna, N., Schumann, J., Chen, B. T., Carman, M., Singh, V., Mailliard, W. S., Ron, D., et al. (2006). Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J. Neurosci. 26, 8549-8558.
55. Seo, D-W., Lopez-Meraz, M-L., Allen, S., Wasterlain, C. G., and Niquet, J. (2009). Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis. J. Neurosci. Res. 87, 2087-2094.
56. Shih, Y-T., Chen, P. S., Wu, C-H., Tseng, Y-T., Wu, Y-C., and Lo, Y-C. (2010). Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement of oxidative stress and suppression of the antioxidant protective system. Free Radic. Biol. Med. 49, 1471-1479.
57. Silva, R. F. M., Falcão, A. S., Fernandes, A., Gordo, A. C., Brito, M. A., and Brites, D. (2006). Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicol. Lett. 163, 1-9.
58. Sim, M. E., Lyoo, I. K., Streeter, C. C., Covell, J., Sarid-Segal, O., Ciraulo, D. A., Kim, M. J., Kaufman, M. J., Yurgelun-Todd, D. A., and Renshaw, P. F. (2007). Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacol. 32, 2229-2237.
59. Smith, D. A., Browning, M., and Dunwiddie, T. V. (1993). Cocaine inhibits hippocampal long-term potentiation. Brain Res. 608, 259-265.
60. Volkow, N. D., Fowler, J. S., and Wang, G-J. (2004). The addicted human brain viewed in the light of imaging studies: Brain circuits and treatments strategies. Neuropharmacology 47, 3-13.
61. Woolf, J. H., Huang, L., Ishiguro, Y., and Morgan, J. P. (1997). Negative inotropic effect of methylecgonidine, a major product of cocaine base pyrolysis, on ferret and human myocardium. J. Cardiovasc. Pharmacol. 30, 352-359.
62. Yuan, C., and Acosta, D. Jr. (2000). Effect of cocaine on mitochondrial electron transport chain evaluated in primary cultures of neonatal rat myocardial cells and in isolated mitochondrial preparations. Drug Chem. Toxicol. 23, 339-348.
63. Zaragoza, A., Díez-Fernández, C., Alvarez, A. M., Andrés, D., and Cascales, M. (2001). Mitochondrial involvement in cocaine-treated rat hepatocytes: Effect of N-acetylcysteine and deferoxamine. Br. J. Pharmacol. 132, 1063-1070.
64. Zhang, C., Lomenzo, S. A., Ballay, C. J., II, and Trudell, M. L. (1997). An improved synthesis of (+)-2-tropinone. J. Org. Chem. 62, 7888-7889.